Literature DB >> 16080234

Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature.

David Hefer1, Mohammed Jaloudi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16080234     DOI： 10.1007/s00277-005-1024-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  Recommendations for the use of albumin and immunoglobulins.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossettias
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

Review 2.  Toxicities of the thrombopoietic growth factors.

Authors:  Adam Cuker
Journal:  Semin Hematol       Date:  2010-07       Impact factor: 3.851

3.  Acute ST Elevation Myocardial Infarction in Patients With Immune Thrombocytopenia Purpura: A Case Report.

Authors:  Sandeep K Dhillon; Edwin Lee; John Fox; Maurice Rachko
Journal:  Cardiol Res       Date:  2011-01-20

Review 4.  Two cases and review of the literature: primary percutaneous angiography and antiplatelet management in patients with immune thrombocytopenic purpura.

Authors:  Estelle Torbey; Harout Yacoub; Donald McCord; James Lafferty
Journal:  ISRN Hematol       Date:  2013-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.